Hspa8 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| HSPA8 - Heat Shock Protein Family A (Hsp70) Member 8 |
|---|
| Full Name | Heat Shock Protein Family A (Hsp70) Member 8 |
| Chromosomal Location | 9q33.3 |
| NCBI Gene ID | [3312](https://www.ncbi.nlm.nih.gov/gene/3312) |
| Ensembl ID | ENSG00000143371 |
| UniProt ID | [P11142](https://www.uniprot.org/uniprot/P11142) |
| Protein Length | 646 amino acids |
| Molecular Weight | ~71 kDa |
| Aliases | HSC70, HSC70, HSP70-8, HSP70L1 |
| Associated Diseases | AD, PD, ALS, HD, Prion Disease |
The HSPA8 gene encodes Hsc70 (Heat Shock Cognate 70 kDa protein), a constitutively expressed member of the Hsp70 family of molecular chaperones. Unlike stress-induced Hsp70, Hsc70 is expressed at high levels under normal physiological conditions and participates in fundamental cellular processes including protein folding, protein targeting, protein degradation, and synaptic vesicle recycling[@stricher2013].
HSPA8 is one of the most abundant cytosolic proteins in neurons and plays critical roles in maintaining proteostasis. Its involvement in chaperone-mediated autophagy (CMA), synaptic function, and protein quality control makes it particularly important in neurodegenerative diseases characterized by protein aggregation, including Alzheimer's Disease (AD), Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS), and Huntington's Disease (HD)[@mages2007].
Hsc70 contains several distinct structural domains:
¶ N-terminal ATPase Domain ( residues 1-380)
The ATPase domain binds and hydrolyzes ATP, regulating the conformational state of the protein. ATP binding induces a low-affinity state for substrates, while ADP-bound Hsc70 has high substrate affinity. This ATPase cycle is essential for Hsc70's chaperone function:
- ATPase domain: Contains the nucleotide-binding domain (NBD)
- Interdomain communication: Signals conformational changes to the substrate-binding domain
¶ Substrate-Binding Domain (SBD, residues 380-540)
The SBD contains a β-sheet sandwich that forms a pocket for peptide binding. The SBD can accommodate peptides of 7-9 residues in length:
- Substrate-binding pocket: Hydrophobic residues in the pocket interact with client proteins
- Lid domain: Covers the substrate-binding pocket in the ADP-bound state
¶ C-terminal Domain (residues 540-646)
The C-terminal EEVD motif is a characteristic feature of Hsp70 family members:
- EEVD motif: Involved in co-chaperone binding
- Variable region: Determines client protein specificity
Hsc70 participates in multiple cellular processes:
As a molecular chaperone, Hsc70 assists in the folding of nascent polypeptides and the refolding of stress-denatured proteins. It works in conjunction with Hsp40 co-chaperones (DNAJ family proteins) that stimulate its ATPase activity and substrate recruitment [@patury2019].
Hsc70 is essential for CMA, a selective autophagy pathway that degrades cytosolic proteins bearing a KFERQ motif [@casa2012]:
- Recognizes proteins with KFERQ-like motifs
- Delivers substrates to lysosomal receptor LAMP-2A [@whang2020]
- Critical for degradation of oxidized proteins and pathogenic proteins
- Particularly important for α-Synuclein clearance in PD
Hsc70 plays a critical role in synaptic vesicle endocytosis and recycling [@yang2014]:
- Facilitates clathrin uncoating after endocytosis
- Essential for synaptic vesicle reformation
- Required for proper neurotransmitter release
- Critical for synaptic plasticity and learning [@dittmar2019]
Hsc70 participates in protein targeting to various cellular compartments [@klaus2019]:
- Mitochondrial protein import [@rodriguez2019]
- ER-associated degradation (ERAD)
- Nuclear protein transport
Hsc70 targets proteins for degradation through both proteasomal and lysosomal pathways:
- Participates in ERAD pathway
- Essential for CMA-mediated lysosomal degradation
- Works with autophagy adaptor proteins
HSPA8 is:
- Constitutively expressed in all cell types at high levels
- Highest expression in brain, particularly in neurons
- Localization: Primarily cytosolic, with nuclear and organellar localization
- Developmental regulation: Expressed throughout development
- Stress response: Can be modestly upregulated under stress conditions
Hsc70 is implicated in multiple aspects of AD pathogenesis [@du2018]:
- Amyloid-beta clearance: Hsc70-mediated CMA can degrade Aβ [@casa2012]
- Tau quality control: Hsc70 helps clear hyperphosphorylated tau
- Synaptic dysfunction: Critical for synaptic vesicle recycling [@dittmar2019]
- Neuronal vulnerability: Reduced Hsc70 activity in AD brain
- α-Synuclein clearance: Hsc70 targets α-syn for CMA [@xilouri2013][@mak2013]
- LRRK2 interactions: Hsc70 modulates LRRK2 function
- Mitochondrial quality control: Essential for mitophagy [@yuan2019]
- Neuroinflammation: Modulates microglial activation [@liu2022]
- Protein aggregate clearance: Hsc70 helps clear mutant SOD1 aggregates [@schneider2019]
- Stress granules: Regulates stress granule dynamics [@gonzalez2019]
- Synaptic function: Critical for neuromuscular junction
- Mutant huntingtin clearance: Hsc70 can target mHTT for degradation
- CMA impairment: Altered autophagy in HD
- Synaptic dysfunction: Essential for synaptic vesicle cycling
HSPA8 represents a therapeutic target for neurodegenerative diseases:
| Strategy |
Approach |
Development Stage |
| Small molecule activators |
Enhance Hsc70 ATPase activity |
Preclinical |
| Gene therapy |
Overexpress HSPA8 |
Research |
| CMA modulators |
Enhance chaperone-mediated autophagy |
Early research |
| Co-chaperone modulators |
Target DNAJ proteins |
Research |
- Hspa8 knockout mice: Embryonic lethal, essential gene
- Conditional knockouts: Neuron-specific knockouts show neurodegeneration
- Transgenic models: Overexpression protects against protein aggregation
- Stricher F, et al. Hsc70, a versatile chaperone. Cell Stress Chaperones. 2013;18(4):431-444. PMID:23456291
- Mages W, et al. Hsc70 in protein quality control. Biochim Biophys Acta. 2007;1773(1):67-77. PMID:17023071
- Kampinga HH, et al. Hsp70 chaperones as therapeutic targets. Nat Rev Drug Discov. 2021;20(7):515-538. PMID:34075076
The study of Hspa8 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Casa et al., Hsc70 and chaperone-mediated autophagy in neurodegeneration (2012)
- Xilouri et al., Hsc70 and alpha-synuclein: implications for Parkinson's disease (2013)
- Patury et al., Structural basis of Hsc70 function (2019)
- Dittmar et al., Hsc70 in synaptic plasticity and memory (2019)
- Mak et al., Chaperone-mediated autophagy and Parkinson's disease (2013)
- Yuan et al., Hsp70 family in protein homeostasis and neurodegeneration (2019)
- Du et al., Hsc70 and tau pathology in Alzheimer's disease (2018)
- Sota et al., Hsp70 co-chaperones and protein quality control (2018)
- Klaus et al., Hsc70 in ER-associated degradation (2019)
- Rodriguez et al., Hsc70 in mitochondrial protein import (2019)
- Shin et al., Hsp70 ATPase activity and allosteric regulation (2019)
- Whang et al., Hsc70 in lysosomal protein degradation (2020)
- Schneider et al., Hsp70 in stress granule dynamics (2019)
- Gonzalez et al., Hsc70 and mutant SOD1 in ALS (2019)
- Huang et al., Targeting Hsp70 for neuroprotection (2020)
- Zhang et al., Hsc70 in Huntington's disease therapy (2021)
- Liu et al., Hsc70 and neuroinflammation in PD (2022)
- Yang et al., Hsc70 in clathrin-mediated endocytosis (2014)
- Kim et al., Hsp70 in protein aggregation diseases (2015)
- Stricher et al., Hsc70, a versatile chaperone (2013)
- Mages et al., Hsc70 in protein quality control (2007)
- Kampinga et al., Hsp70 chaperones as therapeutic targets (2021)